Faculty Opinions recommendation of Structural basis of drug recognition by the multidrug transporter ABCG2.

Author(s):  
Suresh Ambudkar ◽  
Andaleeb Sajid
Nature ◽  
2013 ◽  
Vol 496 (7444) ◽  
pp. 247-251 ◽  
Author(s):  
Yoshiki Tanaka ◽  
Christopher J. Hipolito ◽  
Andrés D. Maturana ◽  
Koichi Ito ◽  
Teruo Kuroda ◽  
...  

2021 ◽  
pp. 166980
Author(s):  
Julia Kowal ◽  
Dongchun Ni ◽  
Scott M. Jackson ◽  
Ioannis Manolaridis ◽  
Henning Stahlberg ◽  
...  

2020 ◽  
Vol 117 (42) ◽  
pp. 26245-26253 ◽  
Author(s):  
Kamil Nosol ◽  
Ksenija Romane ◽  
Rossitza N. Irobalieva ◽  
Amer Alam ◽  
Julia Kowal ◽  
...  

ABCB1 detoxifies cells by exporting diverse xenobiotic compounds, thereby limiting drug disposition and contributing to multidrug resistance in cancer cells. Multiple small-molecule inhibitors and inhibitory antibodies have been developed for therapeutic applications, but the structural basis of their activity is insufficiently understood. We determined cryo-EM structures of nanodisc-reconstituted, human ABCB1 in complex with the Fab fragment of the inhibitory, monoclonal antibody MRK16 and bound to a substrate (the antitumor drug vincristine) or to the potent inhibitors elacridar, tariquidar, or zosuquidar. We found that inhibitors bound in pairs, with one molecule lodged in the central drug-binding pocket and a second extending into a phenylalanine-rich cavity that we termed the “access tunnel.” This finding explains how inhibitors can act as substrates at low concentration, but interfere with the early steps of the peristaltic extrusion mechanism at higher concentration. Our structural data will also help the development of more potent and selective ABCB1 inhibitors.


Cell ◽  
1999 ◽  
Vol 96 (3) ◽  
pp. 353-362 ◽  
Author(s):  
Ekaterina E. Zheleznova ◽  
Penelope N. Markham ◽  
Alexander A. Neyfakh ◽  
Richard G. Brennan

2019 ◽  
Vol 116 (40) ◽  
pp. 19963-19972 ◽  
Author(s):  
Koh Takeuchi ◽  
Misaki Imai ◽  
Ichio Shimada

QacR, a multidrug-binding transcriptional repressor in pathogenic bacteria Staphylococcus aureus, modulates the transcriptional level of the multidrug transporter gene, qacA, in response to engaging a set of diverse ligands. However, the structural basis that defines the variable induction level remains unknown. Here, we reveal that the conformational equilibrium between the repressive and inducive conformations in QacR defines the induction level of the transporter gene. In addition, the unligated QacR is already partly populated in the inducive conformation, allowing the basal expression of the transporter. We also showed that, in the known constitutively active QacR mutants, the equilibrium is shifted more toward the inducive conformation, even in the unligated state. These results highlight the unexpected structural mechanism, connecting the promiscuous multidrug binding to the variable transcriptional regulation of QacR, which provide clues to dysfunctioning of the multidrug resistance systems.


Nature ◽  
2020 ◽  
Vol 578 (7794) ◽  
pp. E19-E19
Author(s):  
Yoshiki Tanaka ◽  
Christopher J. Hipolito ◽  
Andrés D. Maturana ◽  
Koichi Ito ◽  
Teruo Kuroda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document